Page last updated: 2024-08-24

atorvastatin and Hematologic Malignancies

atorvastatin has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brundage, KM; Bunner, P; Craig, MD; Cumpston, A; Gibson, LF; Hamadani, M; Petros, W; Remick, SC; Tse, W; Vos, JA; Wen, S	1

Trials

1 trial(s) available for atorvastatin and Hematologic Malignancies

Article	Year
Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Dec-10, Volume: 31, Issue:35 Topics: Administration, Oral; Adult; Aged; Atorvastatin; Bacterial Infections; Cytokines; Feasibility Studies; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Siblings; Survival Analysis; Tissue Donors; Transplantation Immunology; Transplantation, Homologous; Treatment Outcome; Virus Diseases; Young Adult	2013

Article

Year

Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Dec-10, Volume: 31, Issue:35

Topics: Administration, Oral; Adult; Aged; Atorvastatin; Bacterial Infections; Cytokines; Feasibility Studies; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Siblings; Survival Analysis; Tissue Donors; Transplantation Immunology; Transplantation, Homologous; Treatment Outcome; Virus Diseases; Young Adult

2013